抗凝固藥物及血栓溶解治療在缺血性中風患者的應用 | 合法藥品大搜索

alteplase,tissue-typeplasminogenactivator,tPA）仍是迄今唯一認可的有效治療，各國的中風處置指引皆列為第一證據等級與最強推薦。美國國家神經疾病與中風 ...

E3-5 �ܾ��T�Ī��Φ�귻�Ѫv��b�ʦ�ʤ����w�̪���� Antithrombotic and thrombolytic therapy for ischemic stroke �G�ؿ� �O�j��| ���g���[���������� Jiann-Shing Jeng, MD, PhD Stroke Center & Department of Neurology, National Taiwan University Hospital

�@�@��M�o�Q�Ʀ~����h���Ī���ݯ�Ω��ʸ���뤤�����v��A�R�ߦ�귻�Ѿ���´�ֺ�J�շ�?��E?�]alteplase, tissue-type plasminogen activator, tPA����O�����ߤ@�{�i�����Īv��A�U�ꪺ�����B�m��ެҦC���Ĥ@�Ҿڵ��ŻP�̱j���ˡC����a���g�e�f�P������s�|�]NINDS���1995�~�o���s��ܡA�����o�ͫ�3�p�ɤ��ϥ�tPA�i����ﵽ�������Y���סA���30%�����ݡA��`�v�����ܡA�B����h���X�媺��v�]�g���ʸ��X���v��6.4%�A��Ӳլ�0.6%��A�j�~FDA�Y�֥i�ϥΡC�b�ϥΫ᪺�j�W�ҵn���s�]Safe Implementation of Thrombolysis in Stroke Monitoring Study, SITS-MOST��]�T�߫�ʯʦ夤��3�p�ɤ��v���ĩʻP�w���ʡC�x�W��2002�~�q�L�i�ϥΡA��2006-08�~�x�...